Global Hepatitis C treatment market to grow at CAGR 8% by 2013
The global Hepatitis C Treatment market exhibits a high growth potential market with promising growth prospects inherent for the industry. Other factors that will contribute to the prospective sales are improvements in therapies, increased awareness, and improved diagnosis rates, said the research firm.
The research report reveals that increase in the health insurance industry will drive renewed interests of the investors in the therapeutics market at the global level. Moreover, higher prevalence of lifestyle and chronic diseases such as, diabetes, cancer, arthritis etc. will pave the growth of the market in coming years.
Based on some concrete market fundamentals, the research firm anticipate that the global protein therapeutics industry will witness consolidation in coming years globally during RNCOS' forecast period and will become one of the most dominating market segments of the healthcare industry.
According to the research firm, monoclonal antibodies are the current highest share-holder, but future will see insulin segment posting a rapid growth.
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.